These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 20110149)

  • 1. An evolutionary approach to the high frequency of the Delta F508 CFTR mutation in European populations.
    Alfonso-Sánchez MA; Pérez-Miranda AM; García-Obregón S; Peña JA
    Med Hypotheses; 2010 Jun; 74(6):989-92. PubMed ID: 20110149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do delta F508 heterozygotes have a selective advantage?
    Wiuf C
    Genet Res; 2001 Aug; 78(1):41-7. PubMed ID: 11556136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cystic fibrosis in the Basque country: high frequency of mutation delta F508 in patients of Basque origin.
    Casals T; Vázquez C; Lázaro C; Girbau E; Giménez FJ; Estivill X
    Am J Hum Genet; 1992 Feb; 50(2):404-10. PubMed ID: 1370875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against bronchial asthma by CFTR delta F508 mutation: a heterozygote advantage in cystic fibrosis.
    Schroeder SA; Gaughan DM; Swift M
    Nat Med; 1995 Jul; 1(7):703-5. PubMed ID: 7585155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low prevalence of lactase persistence in Neolithic South-West Europe.
    Plantinga TS; Alonso S; Izagirre N; Hervella M; Fregel R; van der Meer JW; Netea MG; de la Rúa C
    Eur J Hum Genet; 2012 Jul; 20(7):778-82. PubMed ID: 22234158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microsatellite haplotypes of Polish cystic fibrosis alleles: delta F508 chromosomes demonstrate a North-South haplotype frequency gradient.
    Witt M; Reis A; Cichy W; Dziechciowska K
    Hum Hered; 1996; 46(6):310-4. PubMed ID: 8956026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age of the delta F508 cystic fibrosis mutation.
    Kaplan NL; Lewis PO; Weir BS
    Nat Genet; 1994 Nov; 8(3):216-8. PubMed ID: 7533028
    [No Abstract]   [Full Text] [Related]  

  • 8. [A molecular study of the delta-F508 mutation and genetic analysis of a sample of cystic fibrosis patients].
    Orozco L; Lezana JL; Chávez M; Valdez H; Moreno M; Carnevale A
    Bol Med Hosp Infant Mex; 1993 Jul; 50(7):457-62. PubMed ID: 7689846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanomolar affinity small molecule correctors of defective Delta F508-CFTR chloride channel gating.
    Yang H; Shelat AA; Guy RK; Gopinath VS; Ma T; Du K; Lukacs GL; Taddei A; Folli C; Pedemonte N; Galietta LJ; Verkman AS
    J Biol Chem; 2003 Sep; 278(37):35079-85. PubMed ID: 12832418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mouse model for the delta F508 allele of cystic fibrosis.
    Zeiher BG; Eichwald E; Zabner J; Smith JJ; Puga AP; McCray PB; Capecchi MR; Welsh MJ; Thomas KR
    J Clin Invest; 1995 Oct; 96(4):2051-64. PubMed ID: 7560099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Frequency of delta F508 mutation in Venezuelan patients with cystic fibrosis].
    Morales-Machin A; Borjas-Fajardo L; Pineda L; González S; Delgado W; Zabala W; Fernández E
    Invest Clin; 2004 Jun; 45(2):121-30. PubMed ID: 15211979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Screening of the delta-F508 mutation and analysis of two Single Nucleotide Polymorphism of the CFTR gene, in a sample of the general population of Valparaíso, Chile].
    Vera A; Henríquez-Roldán CF; González FJ; Molina G
    Rev Med Chil; 2005 Jul; 133(7):767-75. PubMed ID: 16341382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of delta F508 cystic fibrosis carriers in The Netherlands: logistic regression on sex, age, region of residence and number of offspring.
    de Vries HG; Collée JM; de Walle HE; van Veldhuizen MH; Smit Sibinga CT; Scheffer H; ten Kate LP
    Hum Genet; 1997 Jan; 99(1):74-9. PubMed ID: 9003498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mouse model for the cystic fibrosis delta F508 mutation.
    van Doorninck JH; French PJ; Verbeek E; Peters RH; Morreau H; Bijman J; Scholte BJ
    EMBO J; 1995 Sep; 14(18):4403-11. PubMed ID: 7556083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel natural product compound enhances cAMP-regulated chloride conductance of cells expressing CFTR[delta]F508.
    deCarvalho AC; Ndi CP; Tsopmo A; Tane P; Ayafor J; Connolly JD; Teem JL
    Mol Med; 2002 Feb; 8(2):75-87. PubMed ID: 12080183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A delta F508 mutation in mouse cystic fibrosis transmembrane conductance regulator results in a temperature-sensitive processing defect in vivo.
    French PJ; van Doorninck JH; Peters RH; Verbeek E; Ameen NA; Marino CR; de Jonge HR; Bijman J; Scholte BJ
    J Clin Invest; 1996 Sep; 98(6):1304-12. PubMed ID: 8823295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CFTR haplotypic variability for normal and mutant genes in cystic fibrosis families from southern France.
    Claustres M; Desgeorges M; Moine P; Morral N; Estivill X
    Hum Genet; 1996 Sep; 98(3):336-44. PubMed ID: 8707306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Frequency of mutations and genotypes of the CFTR gene in cystic fibrosis adults in Poland].
    Witt M; Pogorzelski A; Bal J; Rutkiewicz E; Majka L; Sobczyńska A
    Pneumonol Alergol Pol; 1999; 67(3-4):137-41. PubMed ID: 10497446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystic fibrosis with three mutations in the cystic fibrosis transmembrane conductance regulator gene.
    Dörk T; Wulbrand U; Richter T; Neumann T; Wolfes H; Wulf B; Maass G; Tümmler B
    Hum Genet; 1991 Aug; 87(4):441-6. PubMed ID: 1715308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An abnormal distribution of delta F508 genotypes in cystic fibrosis patient registries.
    Feingold J; Guilloud-Bataille M; De Crozes D
    Ann Genet; 1998; 41(1):31-3. PubMed ID: 9599649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.